RUDO MUPOPERI-EXANTUS: Open Payments
NPI 1457175937 · NAUGATUCK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 8 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $146 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $196 |
| Otsuka America Pharmaceutical, Inc. | 2 | $152 |
| Viatris Specialty LLC | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
Products named: NUPLAZID, REXULTI, YUPELRI, AUSTEDO XR.
Industry payments across CT — which companies pay providers there.
